Ligand Pharmaceuticals Inc (NAS:LGND)
$ 122.55 -1.78 (-1.43%) Market Cap: 2.32 Bil Enterprise Value: 2.10 Bil PE Ratio: 48.82 PB Ratio: 2.73 GF Score: 75/100

Ligand Pharmaceuticals Inc To Host Investor Day Transcript

Dec 12, 2023 / 03:30PM GMT
Release Date Price: $62.94 (+0.64%)
Bob Yedid LifeSci Advisors;Managing Director

Okay. I think we're going to get started. My name is Bob Yedid. I'm a Managing Director at LifeSci Advisors. Happy to be working with Ligand. We're delighted that all of you are here today, both in person as well as on the webcast. We planned the full agenda for you and the CEO, Todd Davis, sitting right here, is going to be basically starting off today. If you could save your questions to the end, there will be a Q&A session. And for those who are basically on the webcast, you'll be able to submit your questions in the basic question box on the online call manager.

Before we begin, there will be slides that we're using to guide our discussions. Today, we'll be using non-GAAP financial measures and some of the statements will be forward looking. We'll have a Q&A session to conclude our formal remarks, as I mentioned. Additional information regarding the risks and other matters concerning Ligand could be found in Ligand's summary press release that will be issued later today, along with slides associated with this call, and our periodic

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot